Doxil Articles
US FDA acts on cancer drugs shortages; move applauded by GPhA
22 February 2012
J&J's Doxil plus docetaxel improves TTP
22 December 2008
Ortho Biotech files trabectedin NDA
1 December 2008
Stock Commentary - New York week to July 2, 2007
9 July 2007
Combined Velcade plus Doxil gets FDA OK for MM
28 May 2007
J&J's 4th qtr 2006 EPS beats analysts' estimate
29 January 2007
Ortho Biotech seeks OK for Doxil/Velcade combo
29 January 2007
IDMC recommends Ph III Yondelis trial continues
16 October 2006
Zeltia's Yondelis enters Phase III
11 April 2005
Accelerated US approval for Ortho Biotech's Doxil
14 February 2005
Valentis files patent suit against Alza
18 April 2001
Alza Corp revenues pushing $1 billion
1 February 2001
UK launch for Schering-Plough's Caelyx
31 October 2000
S-P's Caelyx backed for ovarian cancer in EU
5 July 2000
Alza revenues top $200 million mark
20 April 2000
Big sales boost for reformulated drugs
13 March 2000
J&J ends Alza JV for E-TRANS - update
23 February 2000
J&J ends Alza JV for E-TRANS
18 February 2000
Schering-Plough files for EMEA Caelyx OK - updated
3 February 2000
Ethyol approved for dry mouth in USA
1 July 1999
US advisory committee OKs Alza's Doxil
10 June 1999
Alza files sNDA for Doxil
20 April 1999
Alza Boosts Oncology With $580M Sequus Acquisition
6 October 1998
Many US Companies Go Into The Black For 2nd Qtr
5 August 1998
3rd Qtr Revenues Up For US Drug & Biotech Firms
6 November 1997
Sequus' Caelyx Cleared In Australia And New Zealand
18 August 1997
Caelyx Launches
20 March 1997
US Biopharma Firms See Research Bear Fruit In '96
17 February 1997
Sequus' Doxil "More Effective" Than ABV
3 February 1997
Record Number Of New Chemical Entities In 1996
20 January 1997
Excellent Year For The Biotechnology Industry
16 December 1996
US Biopharma Cos Report 3rd-Qtr Financial Results
11 November 1996
Sequus Files To Trial SPI-77 For Tumors
4 November 1996
Schering-Plough And Sequus Link For Caelyx
30 September 1996
Small US Drug Firms Post Quarterly Results
19 August 1996
Amphotec In Bone Marrow Transplants
22 July 1996
Progress At Sequus In 1995 Marked By Doxil Launch
17 June 1996
First Sales Of Sequus' Doxil Reported
15 April 1996
Sequus On Track For Euro Approval Of Doxil
26 February 1996
Sequus' Doxil shipped out
15 January 1996
Sequus Gets First Approval For Doxil
27 November 1995
Results US Biopharmaceutical Firms Progress In Second Quarter
4 September 1995
Lipo Tech Places Units
12 June 1995
Better response with Liposome Technology's Doxil
29 May 1995
LTI STARTS UK PHASE III TRIAL OF DOXIL
8 February 1993
LTI'S DOXIL: EARLY PHASE I RESULTS
15 June 1992
Showing 1-55 of 55 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
